Shane Storey

Shane Storey is an analyst at Wilsons Advisory, known for providing insights into the financial performance of major companies. Recently, he commented on CSL's restructuring plans and the potential impact of Trump’s pharmaceutical tariffs on the company's stock valuation, suggesting that a lower earnings multiple might be appropriate for CSL given its wavering earnings growth despite prior successes.